These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 877599)

  • 1. Oral anticoagulant therapy: the biosynthetic basis.
    Suttie JW
    Semin Hematol; 1977 Jul; 14(3):365-74. PubMed ID: 877599
    [No Abstract]   [Full Text] [Related]  

  • 2. Coumarins and the vitamin K-K epoxide cycle. Lack of resistance to coumatetralyl in warfarin-resistant rats.
    Bell RG; Caldwell PT; Holm EE
    Biochem Pharmacol; 1976 May; 25(9):1067-70. PubMed ID: 1267852
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of action of coumarins. Significance of vitamin K epoxide.
    Sadowski JA; Suttie JW
    Biochemistry; 1974 Aug; 13(18):3696-9. PubMed ID: 4853124
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical basis of hereditary resistance to warfarin in the rat.
    Zimmermann A; Matschiner JT
    Biochem Pharmacol; 1974 Mar; 23(6):1033-40. PubMed ID: 4824903
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of prothrombin synthesis and epoxidation of vitamin K1 by anticoagulants in vitro.
    Bell RG; Stark P
    Biochem Biophys Res Commun; 1976 Sep; 72(2):619-25. PubMed ID: 985502
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitamin K and prothrombin synthesis.
    Suttie JW
    Nutr Rev; 1973 Apr; 31(4):105-9. PubMed ID: 4578889
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats.
    Ren P; Laliberte RE; Bell RG
    Mol Pharmacol; 1974 May; 10(3):373-80. PubMed ID: 4851787
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mechanism of action of vitamin K and how it is affected by anticoagulants].
    Schade R; Janowski K
    Pharmazie; 1976; 31(9):585-9. PubMed ID: 798207
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of vitamin K and prothrombin synthesis: anticoagulants and the vitamin K--epoxide cycle.
    Bell RG
    Fed Proc; 1978 Oct; 37(12):2599-604. PubMed ID: 359368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for competition between vitamin K-dependent clotting factors for intracellular processing by the vitamin K-dependent gamma-carboxylase.
    Stanton C; Ross P; Hutson S; Wallin R
    Thromb Res; 1995 Oct; 80(1):63-73. PubMed ID: 8578539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ineffectiveness of phylloquinone epoxide as an inhibitor of prothrombin synthesis in the rat.
    Goodman SR; Houser RM; Olson RE
    Biochem Biophys Res Commun; 1974 Nov; 61(1):250-7. PubMed ID: 4441396
    [No Abstract]   [Full Text] [Related]  

  • 12. An assay procedure for the vitamin K1 2,3-epoxide-reducing system of rat liver involving high-performance liquid chromatography.
    Elliott GR; Odam EM; Townsend MG
    Biochem Soc Trans; 1976; 4(4):615-7. PubMed ID: 1001726
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K requirement and the concentration of vitamin K in rat liver.
    Knauer TE; Siegfried CM; Matschiner JT
    J Nutr; 1976 Dec; 106(12):1747-51. PubMed ID: 993854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin-induced accumulation of vitamin K-dependent proteins. Comparison between hepatic and non-hepatic tissues.
    Roncaglioni MC; Soute BA; de Boer-vd Berg MA; Vermeer C
    Biochem Biophys Res Commun; 1983 Aug; 114(3):991-7. PubMed ID: 6684427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of vitamin K epoxidase by two non-coumarin anticoagulants.
    Willingham AK; Laliberte RE; Bell RG; Matschiner JT
    Biochem Pharmacol; 1976 May; 25(9):1063-6. PubMed ID: 1267851
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin K1 from vitamin K1 epoxide.
    Ren P; Stark PY; Johnson RL; Bell RG
    J Pharmacol Exp Ther; 1977 Jun; 201(3):541-6. PubMed ID: 864593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin and metabolism of vitamin K1.
    Caldwell PT; Ren P; Bell RG
    Biochem Pharmacol; 1974 Dec; 23(24):3353-62. PubMed ID: 4441421
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacodynamics of the oral anticoagulant drugs.
    O'Reilly RA
    Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticoagulant-resistant rats: possible control by the use of the chloro analog of vitamin K 1 .
    Suttie JW
    Science; 1973 May; 180(4087):741-3. PubMed ID: 4702571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.